Dr. Dana Speer Phillips, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3601 4th St Fl 3, Lubbock, TX 79430 Phone: 806-743-2340 Fax: 806-743-1775 |
News Archive
Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.
Kofax plc, a leading provider of smart process applications for the business critical First Mile of customer interactions, today announced that a US state Medicaid agency invested more than $350,000 in a Kofax solution to improve its medical claims processing efficiency in order to accommodate an increase in claim volume as a result of the Affordable Healthcare Act.
ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership with FIT Biotech, a Finland-based , clinical stage company that develops DNA vaccines. This research will formulate FIT Biotech's GTU MultiHIV DNA plasmid with IVT's DepoVax vaccine delivery system to advance a therapeutic HIV vaccine.
A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.
Eisai Inc. announced today results from the Phase III SELECT trial of investigational agent lenvatinib evaluating progression-free survival (PFS) in patients with progressive radioiodine-refractory differentiated thyroid cancer (RR-DTC).
› Verified 8 days ago